Global Cell Therapy Growth Factors Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cell Therapy Growth Factors Market Insights, Forecast to 2034
Cell therapy growth factors are signaling molecules that play a crucial role in regulating various cellular processes, including cell growth, proliferation, differentiation, and tissue repair. These growth factors are naturally occurring proteins that are produced by cells in the body and act as messengers to communicate instructions for cellular activities. In the context of cell therapy, growth factors are often used to enhance the therapeutic potential of cell-based treatments by influencing cellular behavior and tissue regeneration.
Global Cell Therapy Growth Factors market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cell Therapy Growth Factors industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Cell Therapy Growth Factors key manufacturers include Thermo Fisher Scientific, PeproTech, Bio-Techne, STEMCELL Technologies, BD Biosciences, Merck (Sigma-Aldrich), Sartorius, BioLegend and ProSpec-Tany TechnoGene, etc. Thermo Fisher Scientific, PeproTech, Bio-Techne are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Cell Therapy Growth Factors were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Cell Therapy Growth Factors market and estimated to attract more attentions from industry insiders and investors.
Cell Therapy Growth Factors can be divided into Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-Beta (TGF-β) and Vascular Endothelial Growth Factor (VEGF), etc. Platelet-Derived Growth Factor (PDGF) is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Cell Therapy Growth Factors is widely used in various fields, such as Cell Transplantation, Regenerative Medicine, Tissue Engineering and Others, etc. Cell Transplantation provides greatest supports to the Cell Therapy Growth Factors industry development. In 2022, global % sales of Cell Therapy Growth Factors went into Cell Transplantation filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Cell Therapy Growth Factors market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Cell Therapy Growth Factors market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

Thermo Fisher Scientific
PeproTech
Bio-Techne
STEMCELL Technologies
BD Biosciences
Merck (Sigma-Aldrich)
Sartorius
BioLegend
ProSpec-Tany TechnoGene
Lonza
Sino Biological
GE Healthcare
ACROBiosystems
Core Biogenesis
Proteintech
Segment by Type
Platelet-Derived Growth Factor (PDGF)
Fibroblast Growth Factor (FGF)
Transforming Growth Factor-Beta (TGF-β)
Vascular Endothelial Growth Factor (VEGF)
Nerve Growth Factor (NGF)
Others
Cell Transplantation
Regenerative Medicine
Tissue Engineering
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Cell Therapy Growth Factors plant distribution, commercial date of Cell Therapy Growth Factors, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Cell Therapy Growth Factors introduction, etc. Cell Therapy Growth Factors Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Cell Therapy Growth Factors
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Cell Therapy Growth Factors market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cell Therapy Growth Factors industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Cell Therapy Growth Factors key manufacturers include Thermo Fisher Scientific, PeproTech, Bio-Techne, STEMCELL Technologies, BD Biosciences, Merck (Sigma-Aldrich), Sartorius, BioLegend and ProSpec-Tany TechnoGene, etc. Thermo Fisher Scientific, PeproTech, Bio-Techne are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Cell Therapy Growth Factors were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Cell Therapy Growth Factors market and estimated to attract more attentions from industry insiders and investors.
Cell Therapy Growth Factors can be divided into Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-Beta (TGF-β) and Vascular Endothelial Growth Factor (VEGF), etc. Platelet-Derived Growth Factor (PDGF) is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Cell Therapy Growth Factors is widely used in various fields, such as Cell Transplantation, Regenerative Medicine, Tissue Engineering and Others, etc. Cell Transplantation provides greatest supports to the Cell Therapy Growth Factors industry development. In 2022, global % sales of Cell Therapy Growth Factors went into Cell Transplantation filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Cell Therapy Growth Factors market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Cell Therapy Growth Factors market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Thermo Fisher Scientific
PeproTech
Bio-Techne
STEMCELL Technologies
BD Biosciences
Merck (Sigma-Aldrich)
Sartorius
BioLegend
ProSpec-Tany TechnoGene
Lonza
Sino Biological
GE Healthcare
ACROBiosystems
Core Biogenesis
Proteintech
Segment by Type
Platelet-Derived Growth Factor (PDGF)
Fibroblast Growth Factor (FGF)
Transforming Growth Factor-Beta (TGF-β)
Vascular Endothelial Growth Factor (VEGF)
Nerve Growth Factor (NGF)
Others
Segment by Application
Cell Transplantation
Regenerative Medicine
Tissue Engineering
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Cell Therapy Growth Factors plant distribution, commercial date of Cell Therapy Growth Factors, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Cell Therapy Growth Factors introduction, etc. Cell Therapy Growth Factors Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Cell Therapy Growth Factors
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
